1. Market Research
  2. > Biotechnology
  3. > Genetically Modified Organism Market Trends
  4. > Synthetic Biology Market by Tool, Technology (Bioinformatics, Nanotechnology, Gene Synthesis, Cloning & Sequencing), Application (Biofuels, Pharmaceuticals, Biomaterials, Bioremediation) - Global Forecast to 2018

The synthetic biology market is rapidly evolving, with various technological advancements that have resulted in a paradigm shift within the market. This has resulted in advanced production of synthetic genes and chassis to develop synthetic organisms from scratch.

In 2013, the oligonucleotides segment accounted for the largest share of the global synthetic biology market, by tool, while enabling technologies accounted for the largest share of the synthetic biology market, by technology. The medical application segment accounted for a major share of the synthetic biology applications market in 2013.

North America accounted for the largest share of the global synthetic biology market, followed by Europe, Asia, and the Rest of the World (RoW). In the coming years, Europe is expected to witness the highest growth rate, with emphasis on Germany, U.K., France, Denmark, Switzerland, and Rest of Europe. These countries are expected to serve as revenue pockets for synthetic biology manufacturers.

The global synthetic biology market witnesses high-competitive intensity as there are several big and many small firms with similar product offerings. These companies adopt various strategies (new product launches, acquisitions, and geographical expansions) to increase their market shares and to establish a strong foothold in the global market.

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn helps the firms to garner a greater market share. Firms purchasing the report could use any one or a combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

• Market Penetration: Comprehensive information on the product portfolios offered by the top players in the synthetic biology market. The report analyzes synthetic biology products by tools, technologies, applications, and region

• Product Development/Innovation: Detailed insights on the upcoming technologies, research and development activities, and new product launches in the synthetic biology market

• Market Development: Comprehensive information about the lucrative emerging markets. The report analyzes the markets for various synthetic biology technologies across regions

• Market Diversification: Exhaustive information about new products, untapped regions, recent developments, and investments in the synthetic biology market

• Competitive Assessment: In-depth assessment of the market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the synthetic biology market

Table Of Contents

Synthetic Biology Market by Tool, Technology (Bioinformatics, Nanotechnology, Gene Synthesis, Cloning and Sequencing), Application (Biofuels, Pharmaceuticals, Biomaterials, Bioremediation) - Global Forecast to 2018
TABLE OF CONTENTS

1 INTRODUCTION 16
1.1 OBJECTIVES OF THE STUDY 16
1.2 MARKET DEFINITION 17
1.3 MARKET SCOPE: 17
1.3.1 MARKETS COVERED 17
1.3.2 YEARS CONSIDERED FOR THE STUDY 17
1.4 CURRENCY and PRICING 18
1.5 PACKAGE SIZE 18
1.6 LIMITATIONS 18
1.7 STAKEHOLDERS 18
2 RESEARCH METHODOLOGY 19
2.1.1 SECONDARY AND PRIMARY RESEARCH METHODOLOGY 20
2.1.1.1 Secondary Research 20
2.1.2 KEY DATA FROM SECONDARY SOURCES 20
2.1.2.1 Primary Research 21
2.1.3 KEY DATA FROM PRIMARY SOURCES 23
2.1.4 KEY INSIGHTS FROM PRIMARY SOURCES 23
2.1.5 MARKET SIZE ESTIMATION METHODOLOGY 24
2.1.6 MARKET DATA VALIDATION AND DATA TRIANGULATION 26
2.1.7 ASSUMPTIONS 26
3 EXECUTIVE SUMMARY 27
4 PREMIUM INSIGHTS 31
4.1 GLOBAL SYNTHETIC BIOLOGY MARKET TO WITNESS A HIGH CAGR FROM 2013 TO 2018 31
4.2 SYNTHETIC BIOLOGY MARKET, BY REGION AND APPLICATION 32
4.3 GEOGRAPHIC SNAPSHOT 33
4.4 LIFE CYCLE ANALYSIS, BY GEOGRAPHY 34
5 INDUSTRY SPEAKS 35
5.1 DEMAND SIDE 35
5.2 SUPPLY SIDE 36
6 MARKET OVERVIEW 37
6.1 INTRODUCTION 38
6.2 MARKET DYNAMICS 38
6.2.1 DRIVERS 39
6.2.1.1 Rising RandD expenditure of pharmaceutical and biotechnology companies 39
6.2.1.2 Increasing demand for synthetic genes 39
6.2.1.3 Rise in the global production of genetically modified crops 39
6.2.1.4 Increase in funding 40
6.2.2 RESTRAINT 41
6.2.2.1 Ethical and societal issues 41
6.2.3 CHALLENGE 41
6.2.3.1 Standardization of biological parts 41
6.2.4 OPPORTUNITIES 42
6.2.4.1 Rising concerns on fuel consumption 42
6.2.4.2 Increasing demand for protein therapeutics 42
6.3 PORTER'S FIVE FORCES ANALYSIS 43
6.3.1 THREAT OF NEW ENTRANTS 44
6.3.2 BARGAINING POWER OF SUPPLIERS 44
6.3.3 BARGAINING POWER OF BUYERS 44
6.3.4 SEGMENT RIVALRY 45
6.3.5 THREAT OF SUBSTITUTES 45
6.4 COMPETITIVE POSITIONING OF KEY PLAYERS 45
6.4.1 INTRODUCTION 45
6.4.2 KEY HIGHLIGHTS 46
7 SYNTHETIC BIOLOGY MARKET, BY TOOL 48
7.1 INTRODUCTION 49
7.2 XENO-NUCLEIC ACIDS (XNAS) 52
7.3 CHASSIS ORGANISMS 53
7.4 OLIGONUCLEOTIDES 54
7.5 ENZYMES 55
7.6 CLONING TECHNOLOGY KITS 55
8 SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY 57
8.1 INTRODUCTION 58
8.1.1 ENABLING TECHNOLOGIES 60
8.1.1.1 GENE SYNTHESIS 62
8.1.1.2 BIOINFORMATICS 63
8.1.1.3 GENOME ENGINEERING 64
8.1.1.4 CLONING AND SEQUENCING 65
8.1.1.5 SITE-DIRECTED MUTAGENESIS (SDM) 65
8.1.1.6 MEASUREMENT AND MODELING 66
8.1.1.7 MICROFLUIDICS 67
8.1.1.8 NANOTECHNOLOGY 67
8.1.2 ENABLED TECHNOLOGIES 68
8.1.2.1 PATHWAY ENGINEERING 70
8.1.2.2 NEXT-GENERATION SEQUENCING 70
9 SYNTHETIC BIOLOGY MARKET, BY APPLICATION 72
9.1 INTRODUCTION 73
9.1.1 ENVIRONMENTAL APPLICATIONS 75
9.1.1.1 Bioremediation 77
9.1.1.2 Whole-cell Biosensors 78
9.1.2 MEDICAL APPLICATIONS 78
9.1.2.1 Drug Discovery and Therapeutics 80
9.1.2.2 Pharmaceuticals 81
9.1.2.3 Artificial Tissue and Tissue Regeneration 82
9.1.3 INDUSTRIAL APPLICATIONS 82
9.1.3.1 Biofuel and Renewable Energy 84
9.1.3.2 Industrial Enzymes 85
9.1.3.3 Biomaterials and Green Chemicals 86
10 SYNTHETIC BIOLOGY MARKET, BY GEOGRAPHY 87
10.1 INTRODUCTION 88
10.2 NORTH AMERICA 89
10.2.1 U.S. 93
10.2.1.1 Government Investments propelling the synthetic biology market in the U.S. 93
10.2.1.2 Increase in number of synthetic biology companies and research institutes boosting U.S. market 95
10.2.2 CANADA 95
10.2.2.1 Synthetic biology-related conferences and workshops promoting research activities in Canada 95
10.3 EUROPE 96
10.3.1 EUROPE PRIORITIZING INTERNATIONAL ALLIANCES TO BOOST SYNTHETIC BIOLOGY MARKET 97
10.3.2 HEAVY FUNDING FOR SYNTHETIC BIOLOGY RESEARCH LIKELY TO STIMULATE MARKET GROWTH IN EUROPE 101
10.3.3 U.K. 101
10.3.3.1 Strong government support for synthetic biology in the U.K. 101
10.3.4 GERMANY 103
10.3.4.1 Strong investments driving the synthetic biology market in Germany 103
10.3.5 FRANCE 104
10.3.5.1 Rising awareness to boost synthetic biology market growth in France 104
10.3.6 DENMARK 105
10.3.7 SWITZERLAND 106
10.3.7.1 Switzerland synthetic biology market buoyed by investments 106
10.3.8 REST OF EUROPE (ROE) 107
?
10.4 ASIA 109
10.4.1 CHINA 112
10.4.1.1 Collaborations related to synthetic biology likely to spur innovation and research in synthetic biology in China 113
10.4.1.2 Increasing number of conferences to boost awareness of synthetic biology 114
10.4.2 JAPAN 114
10.4.2.1 Established biotechnology industry makes Japan the leading Asian country in synthetic biology 114
10.4.3 REST OF ASIA (ROA) 116
10.4.3.1 Government investments and conferences stimulating the demand for synthetic biology in the RoA 116
10.5 REST OF THE WORLD (ROW) 118
11 COMPETITIVE LANDSCAPE 122
11.1 OVERVIEW 122
11.2 MARKET SHARE ANALYSIS, SYNTHETIC BIOLOGY MARKET 123
11.2.1 INTRODUCTION 123
11.2.1.1 Thermo Fisher Scientific, Inc. (U.S.) 123
11.2.1.2 Royal DSM N.V. (NETHERLANDS) 124
11.2.1.3 DuPont (U.S.) 125
11.3 COMPETITIVE SITUATION AND TRENDS 125
11.4 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS, AND JOINT VENTURES 127
11.5 NEW PRODUCT LAUNCHES 128
11.6 EXPANSIONS 129
11.7 ACQUISITIONS 130
11.8 OTHERS 131
11.9 EMPIRICAL ASSESSMENT OF GROWTH STRATEGIES 132
11.9.1 ROUTE TO STRATEGIC GROWTH: ORGANIC AND INORGANIC GROWTH STRATEGIES 132
11.9.2 ORGANIC GROWTH STRATEGIES 133
11.9.3 INORGANIC GROWTH STRATEGIES 134
12 COMPANY PROFILES 135
(Overview, Financials, Products and Services, Strategy, and Developments)*
12.1 INTRODUCTION 135
12.2 AMYRIS, INC. 136
12.3 DUPONT 143
12.4 GENSCRIPT USA, INC. 146
12.5 INTREXON CORPORATION 149
12.6 INTEGRATED DNA TECHNOLOGIES (IDT), INC. 154
12.7 NEW ENGLAND BIOLABS, INC. 157
12.8 NOVOZYMES 163
12.9 ROYAL DSM N.V. 168
12.10 SYNTHETIC GENOMICS, INC. 171
12.11 THERMO FISHER SCIENTIFIC, INC. 175
*Details on Financials, Product and Services, Strategy, and Developments might not be captured in case of unlisted companies.
13 APPENDIX 179
13.1 DISCUSSION GUIDE 179
13.2 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 182
13.3 AVAILABLE CUSTOMIZATIONS 183
13.4 RELATED REPORTS 184


LIST OF TABLES

TABLE 1 INCREASING DEMAND FOR SYNTHETIC GENES PROPELLING MARKET GROWTH 40
TABLE 2 ETHICAL AND SOCIETAL ISSUES SUCH AS BIOSAFETY AND BIOSECURITY RESTRAINT MARKET GROWTH 41
TABLE 3 STANDARDIZATION OF BIOLOGICAL PARTS IS A MAJOR CHALLENGE FACED
BY SYNTHETIC BIOLOGY MARKET PLAYERS 42
TABLE 4 RISING CONCERNS ABOUT FUEL CONSUMPTION IS A MAJOR GROWTH OPPORTUNITY IN THE GLOBAL SYNTHETIC BIOLOGY MARKET 43
TABLE 5 SYNTHETIC BIOLOGY MARKET SIZE, BY SEGMENT, 2012-2018 ($MILLION) 49
TABLE 6 SYNTHETIC BIOLOGY MARKET SIZE, BY TOOL, 2012-2018 ($MILLION) 50
TABLE 7 SYNTHETIC BIOLOGY TOOLS MARKET SIZE, BY REGION, 2012-2018 ($MILLION) 51
TABLE 8 SYNTHETIC BIOLOGY MARKET SIZE FOR XENO-NUCLEIC ACIDS, BY REGION,
2012-2018 ($MILLION) 52
TABLE 9 SYNTHETIC BIOLOGY MARKET SIZE FOR CHASSIS ORGANISMS, BY REGION,
2012-2018 ($MILLION) 53
TABLE 10 SYNTHETIC BIOLOGY MARKET SIZE FOR OLIGONUCLEOTIDES, BY REGION,
2012-2018 ($MILLION) 54
TABLE 11 SYNTHETIC BIOLOGY MARKET SIZE FOR ENZYMES, BY REGION,
2012-2018 ($MILLION) 55
TABLE 12 SYNTHETIC BIOLOGY MARKET SIZE FOR CLONING TECHNOLOGY KITS, BY REGION, 2012-2018 ($MILLION) 56
TABLE 13 SYNTHETIC BIOLOGY TECHNOLOGIES MARKET SIZE, BY REGION,
2012-2018 ($MILLION) 59
TABLE 14 SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2012-2018 ($MILLION) 60
TABLE 15 SYNTHETIC BIOLOGY MARKET SIZE FOR ENABLING TECHNOLOGIES, BY REGION, 2012-2018 61
TABLE 16 SYNTHETIC BIOLOGY MARKET SIZE FOR ENABLING TECHNOLOGIES, BY SEGMENT, 2012-2018 61
TABLE 17 SYNTHETIC BIOLOGY MARKET SIZE FOR GENE SYNTHESIS, BY REGION,
2012-2018 ($MILLION) 63
TABLE 18 SYNTHETIC BIOLOGY MARKET FOR BIOINFORMATICS, BY REGION,
2012-2018 ($MILLION) 63
TABLE 19 SYNTHETIC BIOLOGY MARKET SIZE FOR GENOME ENGINEERING,
BY REGION, 2012-2018 ($MILLION) 64
TABLE 20 SYNTHETIC BIOLOGY MARKET SIZE FOR CLONING AND SEQUENCING, BY REGION, 2012-2018 ($MILLION) 65
TABLE 21 SYNTHETIC BIOLOGY MARKET SIZE FOR SITE-DIRECTED MUTAGENESIS,
BY REGION, 2012-2018 ($MILLION) 66
TABLE 22 SYNTHETIC BIOLOGY MARKET SIZE FOR MEASUREMENT AND MODELING,
BY REGION, 2012-2018 ($MILLION) 66
TABLE 23 SYNTHETIC BIOLOGY MARKET SIZE FOR MICROFLUIDICS, BY REGION,
2012-2018 ($MILLION) 67
TABLE 24 SYNTHETIC BIOLOGY MARKET SIZE FOR NANOTECHNOLOGY, BY REGION,
2012-2018 ($MILLION) 68
TABLE 25 SYNTHETIC BIOLOGY MARKET SIZE FOR ENABLED TECHNOLOGIES,
BY REGION, 2012-2018 ($MILLION) 68
TABLE 26 SYNTHETIC BIOLOGY MARKET SIZE FOR ENABLED TECHNOLOGIES,
BY SEGMENT, 2012-2018 ($MILLION) 69
TABLE 27 SYNTHETIC BIOLOGY MARKET SIZE FOR PATHWAY ENGINEERING, BY REGION, 2012-2018 ($MILLION) 70
TABLE 28 SYNTHETIC BIOLOGY MARKET SIZE FOR NEXT-GENERATION SEQUENCING,
BY REGION, 2012-2018 ($MILLION) 71
TABLE 29 SYNTHETIC BIOLOGY APPLICATIONS MARKET SIZE, BY REGION,
2012-2018 ($MILLION) 74
TABLE 30 SYNTHETIC BIOLOGY MARKET SIZE, BY APPLICATION, 2012-2018 ($MILLION) 75
TABLE 31 SYNTHETIC BIOLOGY MARKET SIZE FOR ENVIRONMENTAL APPLICATIONS,
BY REGION, 2012-2018 ($MILLION) 75
TABLE 32 SYNTHETIC BIOLOGY MARKET SIZE FOR ENVIRONMENTAL APPLICATIONS,
BY SEGMENT, 2012-2018 ($MILLION) 76
TABLE 33 SYNTHETIC BIOLOGY MARKET SIZE FOR BIOREMEDIATION, BY REGION,
2012-2018 ($MILLION) 77
TABLE 34 SYNTHETIC BIOLOGY MARKET SIZE FOR WHOLE-CELL BIOSENSORS,
BY REGION, 2012-2018 ($MILLION) 78
TABLE 35 SYNTHETIC BIOLOGY MARKET SIZE FOR MEDICAL APPLICATIONS,
BY REGION, 2012-2018 ($MILLION) 79
TABLE 36 SYNTHETIC BIOLOGY MARKET SIZE FOR MEDICAL APPLICATIONS,
BY SEGMENT, 2012-2018 ($MILLION) 79
TABLE 37 SYNTHETIC BIOLOGY MARKET SIZE FOR DRUG DISCOVERY AND THERAPEUTICS,
BY REGION, 2012-2018 ($MILLION) 81
TABLE 38 SYNTHETIC BIOLOGY MARKET SIZE FOR PHARMACEUTICALS, BY REGION,
2012-2018 ($MILLION) 81
TABLE 39 SYNTHETIC BIOLOGY MARKET SIZE FOR ARTIFICIAL TISSUE AND TISSUE REGENERATION, BY REGION, 2012-2018 ($MILLION) 82
TABLE 40 SYNTHETIC BIOLOGY MARKET SIZE FOR INDUSTRIAL APPLICATIONS,
BY REGION, 2012-2018 ($MILLION) 83
TABLE 41 SYNTHETIC BIOLOGY MARKET SIZE FOR INDUSTRIAL APPLICATIONS,
BY SEGMENT, 2012-2018 ($MILLION) 83
TABLE 42 SYNTHETIC BIOLOGY MARKET SIZE FOR BIOFUEL AND RENEWABLE ENERGY,
BY REGION, 2012-2018 ($MILLION) 85
TABLE 43 SYNTHETIC BIOLOGY MARKET SIZE FOR INDUSTRIAL ENZYMES,
BY REGION, 2012-2014 ($MILLION) 85
TABLE 44 SYNTHETIC BIOLOGY MARKET SIZE FOR BIOMATERIALS AND GREEN CHEMICALS, BY REGION, 2012-2018 ($MILLION) 86
TABLE 45 SYNTHETIC BIOLOGY MARKET SIZE, BY REGION, 2012-2018 ($MILLION) 88
TABLE 46 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET SIZE, BY COUNTRY,
2012-2018 ($MILLION) 90
TABLE 47 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET SIZE, BY SEGMENT,
2012-2018 ($MILLION) 91
TABLE 48 NORTH AMERICA: SYNTHETIC BIOLOGY TOOLS MARKET SIZE,
2012-2018 ($MILLION) 91
TABLE 49 NORTH AMERICA: SYNTHETIC BIOLOGY TECHNOLOGIES MARKET SIZE,
2012-2018 ($MILLION) 92
TABLE 50 NORTH AMERICA: SYNTHETIC BIOLOGY ENABLING TECHNOLOGIES MARKET SIZE, 2012-2018 ($MILLION) 92
TABLE 51 NORTH AMERICA: SYNTHETIC BIOLOGY ENABLED TECHNOLOGIES MARKET SIZE, 2012-2018 ($MILLION) 93
TABLE 52 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET SIZE, BY APPLICATION,
2012-2018 ($MILLION) 93
TABLE 53 U.S.: SYNTHETIC BIOLOGY MARKET SIZE, BY SEGMENT, 2012-2018 ($MILLION) 94
TABLE 54 U.S.: SYNTHETIC BIOLOGY MARKET SIZE, BY APPLICATION,
2012-2018 ($MILLION) 94
TABLE 55 CANADA: SYNTHETIC BIOLOGY MARKET SIZE, BY SEGMENT,
2012-2018 ($MILLION) 95
TABLE 56 CANADA: SYNTHETIC BIOLOGY MARKET SIZE, BY APPLICATION,
2012-2018 ($MILLION) 96
TABLE 57 EUROPE: SYNTHETIC BIOLOGY MARKET SIZE, BY COUNTRY,
2012-2018 ($MILLION) 98
TABLE 58 EUROPE: SYNTHETIC BIOLOGY MARKET SIZE, BY SEGMENT,
2012-2018 ($MILLION) 98
TABLE 59 EUROPE: SYNTHETIC BIOLOGY TOOLS MARKET SIZE, 2012-2018 ($MILLION) 99
TABLE 60 EUROPE: SYNTHETIC BIOLOGY TECHNOLOGIES MARKET SIZE,
2012-2018 ($MILLION) 99
TABLE 61 EUROPE: SYNTHETIC BIOLOGY ENABLING TECHNOLOGIES MARKET SIZE,
2012-2018 ($MILLION) 100
TABLE 62 EUROPE: SYNTHETIC BIOLOGY ENABLED TECHNOLOGIES MARKET SIZE,
2012-2018 ($MILLION) 100
TABLE 63 EUROPE: SYNTHETIC BIOLOGY MARKET SIZE, BY APPLICATION,
2012-2018 ($MILLION) 101
TABLE 64 U.K.: SYNTHETIC BIOLOGY MARKET SIZE, BY SEGMENT, 2012-2018 ($MILLION) 102
TABLE 65 U.K.: SYNTHETIC BIOLOGY MARKET SIZE, BY APPLICATION,
2012-2018 ($MILLION) 102
TABLE 66 GERMANY: SYNTHETIC BIOLOGY MARKET SIZE, BY SEGMENT,
2012-2018 ($MILLION) 103
TABLE 67 GERMANY: SYNTHETIC BIOLOGY MARKET SIZE, BY APPLICATION,
2012-2018 ($MILLION) 103
TABLE 68 FRANCE: SYNTHETIC BIOLOGY MARKET SIZE, BY SEGMENT,
2012-2018 ($MILLION) 104
TABLE 69 FRANCE: SYNTHETIC BIOLOGY MARKET SIZE, BY APPLICATION,
2012-2018 ($MILLION) 105
TABLE 70 DENMARK: SYNTHETIC BIOLOGY MARKET SIZE, BY SEGMENT,
2012-2018 ($MILLION) 105
TABLE 71 DENMARK: SYNTHETIC BIOLOGY MARKET SIZE, BY APPLICATION,
2012-2018 ($MILLION) 106
TABLE 72 SWITZERLAND: SYNTHETIC BIOLOGY MARKET SIZE, BY SEGMENT,
2012-2018 ($MILLION) 107
TABLE 73 SWITZERLAND: SYNTHETIC BIOLOGY MARKET SIZE, BY APPLICATION,
2012-2018 ($MILLION) 107
TABLE 74 ROE: SYNTHETIC BIOLOGY MARKET SIZE, BY SEGMENT, 2012-2018 ($MILLION) 108
TABLE 75 ROE: SYNTHETIC BIOLOGY MARKET SIZE, BY APPLICATION,
2012-2018 ($MILLION) 108
TABLE 76 ASIA: SYNTHETIC BIOLOGY MARKET SIZE, BY COUNTRY, 2012-2018 ($MILLION) 109
TABLE 77 ASIA: SYNTHETIC BIOLOGY MARKET SIZE, BY SEGMENT, 2012-2018 ($MILLION) 110
TABLE 78 ASIA: SYNTHETIC BIOLOGY TOOLS MARKET SIZE, 2012-2018 ($MILLION) 110
TABLE 79 ASIA: SYNTHETIC BIOLOGY TECHNOLOGIES MARKET SIZE, 2012-2018 ($MILLION) 111
TABLE 80 ASIA: SYNTHETIC BIOLOGY ENABLING TECHNOLOGIES MARKET SIZE,
2012-2018 ($MILLION) 111
TABLE 81 ASIA: SYNTHETIC BIOLOGY ENABLED TECHNOLOGIES MARKET SIZE,
2012-2018 ($MILLION) 112
TABLE 82 ASIA: SYNTHETIC BIOLOGY MARKET SIZE, BY APPLICATION,
2012-2018 ($MILLION) 112
TABLE 83 CHINA: SYNTHETIC BIOLOGY MARKET SIZE, BY SEGMENT, 2012-2018 ($MILLION) 113
TABLE 84 CHINA: SYNTHETIC BIOLOGY MARKET SIZE, BY APPLICATION,
2012-2018 ($MILLION) 114
TABLE 85 JAPAN: SYNTHETIC BIOLOGY MARKET SIZE, BY SEGMENT, 2012-2018 ($MILLION) 115
TABLE 86 JAPAN: SYNTHETIC BIOLOGY MARKET SIZE, BY APPLICATION,
2012-2018 ($MILLION) 115
TABLE 87 ROA: SYNTHETIC BIOLOGY MARKET SIZE, BY SEGMENT, 2012-2018 ($MILLION) 117
TABLE 88 ROA: SYNTHETIC BIOLOGY MARKET SIZE, BY APPLICATION,
2012-2018 ($MILLION) 117
TABLE 89 ROW: SYNTHETIC BIOLOGY MARKET SIZE, BY SEGMENT, 2012-2018 ($MILLION) 119
TABLE 90 ROW: SYNTHETIC BIOLOGY TOOLS MARKET SIZE, 2012-2018 ($MILLION) 119
TABLE 91 ROW: SYNTHETIC BIOLOGY TECHNOLOGIES MARKET SIZE, 2012-2018 ($MILLION) 120
TABLE 92 ROW: SYNTHETIC BIOLOGY ENABLING TECHNOLOGIES MARKET SIZE,
2012-2018 ($MILLION) 120
TABLE 93 ROW: SYNTHETIC BIOLOGY ENABLED TECHNOLOGIES MARKET SIZE,
2012-2018 ($MILLION) 121
TABLE 94 ROW: SYNTHETIC BIOLOGY MARKET SIZE, BY APPLICATION,
2012-2018 ($MILLION) 121
TABLE 95 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS, AND JOINT VENTURES,
2011-2014 127
TABLE 96 NEW PRODUCT LAUNCHES, 2011-2013 128
TABLE 97 EXPANSIONS, 2011-2014 129
TABLE 98 ACQUISITIONS, 2011-2014 130
TABLE 99 OTHERS, 2011-2014 131


LIST OF FIGURES

FIGURE 1 SYNTHETIC BIOLOGY MARKET SEGMENTATION 17
FIGURE 2 GLOBAL SYNTHETIC BIOLOGY MARKET: RESEARCH METHODOLOGY STEPS 19
FIGURE 3 SAMPLING FRAME: PRIMARY RESEARCH 22
FIGURE 4 BREAK DOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 22
FIGURE 5 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH 24
FIGURE 6 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 25
FIGURE 7 MARKET FORECAST METHODOLOGY 25
FIGURE 8 DATA TRIANGULATION METHODOLOGY 26
FIGURE 9 GLOBAL SYNTHETIC BIOLOGY MARKET SNAPSHOT, BY SEGMENT, 2013-2018 27
FIGURE 10 ENABLING TECHNOLOGIES MARKET SEGMENT TO WITNESS HIGHEST CAGR OF 24.8% FROM 2013 TO 2018 28
FIGURE 11 GLOBAL SYNTHETIC BIOLOGY MARKET, BY APPLICATION 2013 29
FIGURE 12 GLOBAL SYNTHETIC BIOLOGY MARKET, BY GEOGRAPHY, 2013 29
FIGURE 13 SYNTHETIC BIOLOGY: MARKET OVERVIEW 31
FIGURE 14 NORTH AMERICA TO DOMINATE THE SYNTHETIC BIOLOGY MARKET IN 2013 32
FIGURE 15 EUROPE TO WITNESS THE HIGHEST CAGR DURING THE FORECAST PERIOD 33
FIGURE 16 GLOBAL SYNTHETIC BIOLOGY MARKET TO WITNESS SIGNIFICANT GROWTH IN THE COMING YEARS 34
FIGURE 17 INCREASING DEMAND FOR SYNTHETIC GENES TO SPUR MARKET GROWTH 38
FIGURE 18 PORTER'S FIVE FORCES ANALYSIS: SYNTHETIC BIOLOGY MARKET 43
FIGURE 19 COMPETITIVE POSITIONING, BY KEY PLAYER (2014) 46
FIGURE 20 TECHNOLOGIES SEGMENT TO GROW AT A HIGHER PACE IN THE FORECAST PERIOD 49
FIGURE 21 EUROPE TO BE THE FASTEST-GROWING SYNTHETIC BIOLOGY MARKET, BY TOOL FROM 2013 TO 2018 50
FIGURE 22 OLIGONUCLEOTIDES SEGMENT COMMANDED LARGEST MARKET SHARE IN 2013 51
FIGURE 23 SYNTHETIC BIOLOGY TECHNOLOGIES MARKET, 2013 VS. 2018 58
FIGURE 24 SYNTHETIC BIOLOGY TECHNOLOGY MARKET IN EUROPE TO GROW AT HIGHEST CAGR IN FORECAST PERIOD 59
FIGURE 25 ENABLING TECHNOLOGIES SEGMENT TO GROW AT HIGHER CAGR OF 24.8% 60
FIGURE 26 BIOINFORMATICS SEGMENT TO GROW AT HIGHEST CAGR OF 26.2% IN FORECAST PERIOD 62
FIGURE 27 NEXT-GENERATION SEQUENCING TO GROW AT HIGHER CAGR OF 24.9% 69
FIGURE 28 SYNTHETIC BIOLOGY APPLICATIONS MARKET, 2013 VS. 2018 73
FIGURE 29 MEDICAL TO GROW AT THE HIGHEST CAGR IN THE GLOBAL SYNTHETIC BIOLOGY APPLICATIONS MARKET 74
FIGURE 30 BIOREMEDIATION TO GROW AT THE HIGHEST CAGR OF 23% 76
FIGURE 31 DRUG DISCOVERY AND THERAPEUTICS SEGMENT TO GROW AT THE HIGHEST CAGR 80
FIGURE 32 BIOFUEL AND RENEWABLE ENERGY SEGMENT ACCOUNTED FOR A SHARE OF 53% OF THE SYNTHETIC BIOLOGY MARKET IN 2013 84
FIGURE 33 SYNTHETIC BIOLOGY MARKET IN EUROPE TO GROW AT HIGHEST CAGR FROM 2013 TO 2018 89
FIGURE 34 NORTH AMERICA ACCOUNTED FOR LARGEST SHARE OF SYNTHETIC BIOLOGY MARKET (2013) 90
FIGURE 35 U.K. TO BE THE FASTEST-GROWING MARKET FOR SYNTHETIC BIOLOGY IN EUROPE 97
FIGURE 36 COMPANIES ADOPTED AGREEMENTS, PARTNERSHIPS, COLLABORATIONS, AND JOINT VENTURES AS KEY GROWTH STRATEGY IN LAST THREE YEARS 122
FIGURE 37 MARKET SHARE ANALYSIS, BY KEY PLAYER, 2013 123
FIGURE 38 KEY GROWTH STRATEGIES OF THE GLOBAL SYNTHETIC BIOLOGY MARKET,
2011-2014 126
FIGURE 39 BATTLE FOR MARKET SHARE: AGREEMENTS, PARTNERSHIPS, COLLABORATION, AND JOINT VENTURES ARE THE KEY STRATEGIES 126
FIGURE 40 ORGANIC AND INORGANIC GROWTH STRATEGIES 132
FIGURE 41 ORGANIC GROWTH STRATEGIES, BY KEY PLAYER (2011-2014) 133
FIGURE 42 INORGANIC GROWTH STRATEGIES, BY KEY PLAYER (2011-2014) 134
FIGURE 43 GEOGRAPHICAL REVENUE MIX OF TOP 4 PLAYERS 135
FIGURE 44 DUPONT: COMPANY SNAPSHOT 143
FIGURE 45 GENSCRIPT USA INC.: COMPANY SNAPSHOT 146
FIGURE 46 INTREXON CORPORATION : COMPANY SNAPSHOT 149
FIGURE 47 INTEGRATED DNA TECHNOLOGIES (IDT): COMPANY SNAPSHOT 154
FIGURE 48 NEW ENGLAND BIOLABS, INC.: COMPANY SNAPSHOT 157
FIGURE 49 COMPANY SNAPSHOT 168
FIGURE 50 SYNTHETIC GENOMICS, INC.: COMPANY SNAPSHOT 171
FIGURE 51 COMPANY SNAPSHOT 175

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Synthetic Biology: Global Markets

Synthetic Biology: Global Markets

  • $ 6650
  • Industry report
  • January 2017
  • by BCC Research

Report Highlights The global synthetic-biology market reached nearly $3.9 billion in 2016 and should reach $11.4 billion by 2021, growing at a compound annual growth rate (CAGR) of 24.0% through 2021. ...

Genome Editing: Technologies and Global Markets

Genome Editing: Technologies and Global Markets

  • $ 6650
  • Industry report
  • March 2016
  • by BCC Research

This BCC Research report provides detailed market and industry analyses of the rapidly growing global market for genome editing. Important trends of the field and market segments are identified, and market ...

Transfection Reagents and Equipment Market by Method, Physical, Viral, Application, End User - Global Forecast to 2021

Transfection Reagents and Equipment Market by Method, Physical, Viral, Application, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • January 2017
  • by MarketsandMarkets

The global transfection reagents and equipment market is expected to reach USD 1.02 billion by 2021 from USD 715.4 million in 2016, at a CAGR of 7.5% during the forecast period 2016 to 2021. Over the years, ...


ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.